Tocqueville Asset Management L.P. bought a new position in Danaher Corporation (NYSE:DHR – Free Report) during the second quarter, according to its most recent disclosure with the SEC. The firm bought 17,540 shares of the conglomerate’s stock, valued at approximately $12,630,000.
Several other institutional investors and hedge funds also recently bought and sold shares of the stock. High Note Wealth LLC grew its holdings in Danaher by 19.2% during the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock valued at $67,000 after purchasing an additional 47 shares during the period. First Command Advisory Services Inc. raised its stake in shares of Danaher by 4.4% in the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock worth $253,000 after buying an additional 47 shares during the period. GW&K Investment Management LLC lifted its position in shares of Danaher by 8.4% during the 4th quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock valued at $138,000 after buying an additional 47 shares in the last quarter. Kestra Private Wealth Services LLC lifted its position in shares of Danaher by 0.3% during the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock valued at $3,057,000 after buying an additional 48 shares in the last quarter. Finally, SOL Capital Management CO grew its stake in shares of Danaher by 2.7% during the 4th quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate’s stock valued at $430,000 after acquiring an additional 50 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.
Danaher Stock Up 6.2%
Shares of DHR opened at $211.92 on Thursday. The business’s 50 day moving average is $194.30 and its 200 day moving average is $192.44. The company has a market capitalization of $148.98 billion, a PE ratio of 37.64, a price-to-earnings-growth ratio of 2.49 and a beta of 0.78. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.
Wall Street Analysts Forecast Growth
Several equities research analysts recently issued reports on the stock. Piper Sandler started coverage on shares of Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price for the company. Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Evercore reiterated an “outperform” rating and issued a $230.00 price target on shares of Danaher in a research report on Monday, July 6th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $240.00 price objective on shares of Danaher in a research note on Wednesday, July 22nd. Finally, Royal Bank Of Canada raised their price objective on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $228.91.
Read Our Latest Report on Danaher
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
